ATC Group: J05AG Non-nucleoside reverse transcriptase inhibitors

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J05AG in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J05 Antivirals for systemic use
3 J05A Direct acting antivirals
4 J05AG Non-nucleoside reverse transcriptase inhibitors

Group J05AG contents

Code Title
J05AG01 Nevirapine
J05AG02 Delavirdine
J05AG03 Efavirenz
J05AG04 Etravirine
J05AG05 Rilpivirine
J05AG06

Active ingredients in J05AG

Active Ingredient Description
Doravirine

Doravirine is a pyridinone non-nucleoside reverse transcriptase inhibitor of HIV-1 and inhibits HIV-1 replication by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Doravirine does not inhibit the human cellular DNA polymerases α, β, and mitochondrial DNA polymerase γ.

Efavirenz

Efavirenz is a NNRTI of HIV-1. Efavirenz is a non-competitive inhibitor of HIV-1 reverse transcriptase (RT) and does not significantly inhibit HIV-2 RT or cellular DNA polymerases (α, β, γ or δ).

Etravirine

Etravirine is an non-nucleoside reverse transcriptase inhibitors (NNRTI) of human immunodeficiency virus type 1 (HIV-1). Etravirine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme’s catalytic site.

Nevirapine

Nevirapine is a NNRTI of HIV-1. Nevirapine is a non-competitive inhibitor of the HIV-1 reverse transcriptase, but it does not have a biologically significant inhibitory effect on the HIV-2 reverse transcriptase or on eukaryotic DNA polymerases α, β, γ, or δ.

Rilpivirine

Rilpivirine is a diarylpyrimidine NNRTI of HIV-1. Rilpivirine activity is mediated by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Rilpivirine does not inhibit the human cellular DNA polymerases α, β and γ.

Related product monographs

Title Information Source Document Type  
EDURANT Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
EFRIN Film-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic
INTELENCE Tablet European Medicines Agency (EU) MPI, EU: SmPC
NEVIRAPINE TEVA Tablet European Medicines Agency (EU) MPI, EU: SmPC
PIFELTRO Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
REKAMBYS Prolonged-release suspension for injection European Medicines Agency (EU) MPI, EU: SmPC
STOCRIN Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC